<DOC>
	<DOC>NCT00495885</DOC>
	<brief_summary>The purpose of this study is to assess efficacy and safety of volinanserin in the population of patients complaining of sleep maintenance insomnia. The objective of the substudy is to assess glycemic control in the subgroup of patients with type II diabetes mellitus.</brief_summary>
	<brief_title>Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>MDL 100907</mesh_term>
	<criteria>Diagnosis of primary insomnia based on Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria Disturbances of sleep maintenance criteria based on patient's information related to sleep pattern during the preceding month Substudy : Patients will be included if they have an established medical diagnosis of type II Diabetes Mellitus, and have been treated either with an oral hypoglycemic agent and/or insulin for at least three months prior to the Screening Visit (with stable regimen for at least one month prior to screening) Females who are lactating or who are pregnant Night shift workers, and individuals who nap 3 or more times per week over the preceding month Consumption of xanthinecontaining beverages (i.e. tea, coffee, cola) comprising more than 5 cups/day Participation in another trial having received study medication within 1 month before the screening visit Body Mass Index ≥ 33 Use of overthecounter medications such as tryptophan, valerian root, kava, melatonin, St. John's Wort, Alluna or prescription sleep medication Use of any substance with psychotropic effects or properties know to affect sleep/wake History of primary hypersomnia, narcolepsy, breathingrelated sleep disorder, circadian rhythm sleep disorder, parasomnia, dyssomnia Clinically significant, severe or unstable, acute or chronically progressive medical or surgical disorder Positive qualitative urine drug screen (opiates, cocaine, amphetamine…) The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Sleep problems</keyword>
	<keyword>insomnia</keyword>
	<keyword>sleeplessness</keyword>
	<keyword>primary insomnia</keyword>
	<keyword>insomnia disorder</keyword>
</DOC>